Non-alcoholic steatohepatitis (NASH) is a condition characterized by excessive deposition of lipids in the liver (steatosis), inflammation and hepatocellular necrosis. The evolution of steatosis can lead to the appearance of hepatic fibrosis (scarring) and progresses to cirrhosis. Cirrhosis is one of the main causes of liver transplantation.

Currently, no treatment has been approved. In order to advance the discovery of therapeutic options, Medpharmgene participated in 3 NASH studies. Our facilities and partnerships provide Fibroscan and liver biopsies. - canadian online casinos